“The non-communicable disease [NCD] community always talks about the importance of prevention; many consider it the Holy Grail in the fight against NCDs. Why was it so hard to also accept treatment as part of the solution?” Princess Dina Mired, director general of the King Hussein Cancer Foundation in Amman, Jordan, asks in the Huffington Post “Impact” blog, noting only one target of the 2011 U.N. High-Level Meeting on NCDs “deals with treatment, the target on ‘essential medicines and basic technologies for treatment.’” She continues, “Treatment and prevention are heavily interrelated. The success of one is directly related to the other.” She adds, “A person in the developing world will not buy in to the importance of prevention if there is no treatment option available should that person get the disease.”
Quality of Care
“As many as 200 million children across the world fail to reach their full potential because their early brain development is held back by poverty, disease and malnutrition, global health experts said on Thursday,” Reuters reports (Kelland, 9/13). The Canadian government-funded Grand Challenges Canada on Thursday “announced $11.8 million CAD [$12 million] in funding over two years for 11 bold ideas from innovators in the developing world, to address health conditions causing diminished cognitive potential and stunting,” according to a Grand Challenges Canada press release (9/13). The projects, which will be implemented in developing countries such as Thailand, Pakistan, Bangladesh, and Colombia, “include plans to encourage so-called ‘kangaroo mother care,’ where low-weight newborns are held skin to skin rather than put into incubators, and ways of combating maternal depression to boost interaction between mothers and babies,” Reuters notes (9/13).
The Center for Strategic and International Studies (CSIS) on Thursday hosted a panel discussion focusing on the policy implications of findings published by the Lancet in a special series on HIV/AIDS and men who have sex with men (MSM), the Center for Global Health Policy’s “Science Speaks” blog reports (Barton, 9/7). Chris Beyrer, a professor of international health at the Johns Hopkins Bloomberg School of Public Health and a contributor to the Lancet series, explained two factors are affecting the expansion of the HIV epidemic among MSM worldwide, according to Inter Press Service. First, HIV “is far more efficiently transmitted through the gut, hence leading to a far higher transmission probability in anal sex, for either a man or a woman — around 18 times more likely than through vaginal transmission,” the news service writes. Second, “because gay men can switch sexual roles in a way that is impossible among heterosexual couples — acting as both the acquisition and transmission partner — the efficiency of transmission among MSM networks appears to be far higher than previously understood,” IPS adds, noting, “These two factors, the new research suggests, account for a full 98 percent of the difference between HIV epidemics among MSM and heterosexual populations.”
“The worldwide counterfeit drug market is huge and growing,” Tim Mackey and Brian Liang of the Institute of Health Law Studies at the California Western School of Law and Thomas Kubic of the Pharmaceutical Security Institute write in a Foreign Policy opinion piece, noting such “drugs occupy a wide spectrum of medications, and their quality is suspect; they can be mislabeled, tainted, adulterated, ineffective, or, in the worst cases, all of the above.” They argue for a new framework for fighting the illegal drug trade because “[g]lobal policy has not kept up with the burgeoning counterfeit drug trade.” The authors say that although initial results of the WHO IMPACT (International Medical Products Anti-Counterfeit Taskforce) are “encouraging,” they note that “[s]ome WHO member states, including India and Brazil (both top producers of generic drugs) and other developing countries, have questioned whether WHO can rightly take on enforcement operations” because it “is not a global law enforcement agency.”
“Counterfeit, falsified, and substandard drugs are a dangerous threat to people around the world, including Americans,” therefore “we have a vital interest in ensuring the safety of an ever more complex global drug supply chain,” Jennifer White, a foreign service officer in the Office of International Health and Biodefense in the Bureau of Oceans and International Environmental and Scientific Affairs, writes in a post in the State Department’s “DipNote” blog. She notes that the “Department of State engages in the fight against counterfeit medicines using a multi-faceted approach,” including training foreign drug regulators; funding consumer outreach to raise awareness of the problem; being active in international bodies that address counterfeiting, such as the WHO; and “work[ing] in partnership with other U.S. government agencies, the health care community, patients, civil society, and the pharmaceutical industry to ensure that patients receive safe medicines and that those who put patients’ lives at risk can be prosecuted” (5/22).
More Research Needed Into How Transgender Persons In Asia, Pacific Affected By HIV, Stigma, Report Says
A report released Thursday in Bangkok by the United Nations Development Programme (UNDP) and the Asia Pacific Transgender Network (APTN) says more research needs to be conducted to determine the extent to which transgender persons in Asia and the Pacific are affected by HIV, are socially ostracized, and lack fundamental rights, including access to basic health care, a UNDP press release reports. The report, released to mark the International Day Against Homophobia and Transphobia, is “a comprehensive review of material gathered from across the region over the past 12 years” and “emphasizes that inclusive research, designed and implemented in partnership with the transgender community, is critical to enable governments, community-based organizations and supporting organizations to enhance HIV and sexual health care services specific to the needs of transgender people, and foster action by governments to adopt more socially equitable policies and practices to protect their rights,” according to the press release (5/17).
“Just two years ago, our country had one of the worst maternal and infant death rates in the world,” Sierra Leone President Ernest Bai Koroma writes in a Huffington Post U.K. “Impact” blog post, adding, “We knew something had to be done.” So in September 2009, the government announced “that all health user fees would be removed for pregnant and lactating women and children under the age of five” and “introduced the Free Health Care Initiative [FHCI] in April 2010, which would give around 460,000 women and a million children a much better chance of having a longer and happier life,” Koroma writes. In one year, the FHCI facilitated a “214 percent increase in the number of children attending outpatient units” and a 61 percent reduction in “the number of women dying from pregnancy complications at facilities,” and “increased the number of health workers and ensured they were given big salary rises to reflect the importance of their positions,” he notes.
The argument that “a country’s quickest way to better health for its people is economic development … is only one factor, and not the most important one, in explaining global health outcomes,” Charles Kenny, a senior fellow at the Center for Global Development, writes in a SciDev.Net opinion piece. “The challenge is to ensure that a cheap basic package of health interventions is available to — and is used by — all,” he continues.
The U.S. Army in a news article on its website reports on how it is working to “bring virtual health care to Albanian hospitals” through a telemedicine program that “aims to link different levels of health care to ensure a better functioning and sustainable system.” According to the article, “Currently, five of the 12 major regional hospitals in Albania are connected via a hub-and-spoke information technology system to the central e-heath center in Tirana,” and, “[b]y March of this year, three additional hospitals will have the infrastructure in place to connect to the network.”
In this post on IntraHealth’s “Global Health Blog,” Pape Gaye, president and CEO of IntraHealth, discusses the organization’s commitment to providing quality training to Kenyan health care workers made at this year’s Clinton Global Initiative meeting. “We and our partners will use information technologies designed or adapted in Kenya to create and distribute training programs to Kenyan health workers. We are especially focusing on health workers who provide much-needed services in the remote Kenyan regions of Kitui and Kisumu,” Gaye writes. Noting that “one billion people in this world who may never come in contact with a health provider in their entire lives,” he continues, “I hope that by making the information and the training available where it’s needed the most, we are giving a chance to these people, a chance to get in contact with and receive services from a health worker” (10/9).